B
Bio-Works Technologies AB
STO:BIOWKS
Bio-Works Technologies AB
STO:BIOWKS
Price:
3.2
SEK
-3.9%
Market Closed
Market Cap:
kr249.5m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
B
|
Bio-Works Technologies AB
STO:BIOWKS
|
SE |
|
Nanjing Hicin Pharmaceutical Co Ltd
SZSE:300584
|
CN |
|
Shanghai Guao Electronic Technology Co Ltd
SZSE:300551
|
CN |
Balance Sheet
Balance Sheet Decomposition
Bio-Works Technologies AB
Bio-Works Technologies AB
Balance Sheet Decomposition is not available for
Bio-Works Technologies AB
Bio-Works Technologies AB
Balance Sheet
Bio-Works Technologies AB
Bio-Works Technologies AB
Currency: SEK
| Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & Cash Equivalents |
10
|
13
|
89
|
54
|
76
|
33
|
103
|
66
|
39
|
|
| Cash |
10
|
13
|
89
|
54
|
76
|
33
|
103
|
66
|
39
|
|
| Total Receivables |
1
|
1
|
2
|
3
|
2
|
3
|
6
|
11
|
8
|
|
| Accounts Receivables |
1
|
1
|
1
|
2
|
1
|
1
|
5
|
8
|
7
|
|
| Other Receivables |
0
|
0
|
1
|
0
|
1
|
2
|
2
|
3
|
1
|
|
| Inventory |
3
|
4
|
4
|
6
|
7
|
7
|
8
|
10
|
9
|
|
| Other Current Assets |
0
|
0
|
1
|
1
|
1
|
1
|
2
|
3
|
3
|
|
| Total Current Assets |
14
|
18
|
96
|
64
|
86
|
44
|
119
|
89
|
60
|
|
| PP&E Net |
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
2
|
|
| Intangible Assets |
10
|
9
|
6
|
1
|
1
|
0
|
0
|
0
|
0
|
|
| Goodwill |
0
|
0
|
2
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Assets |
0
|
0
|
2
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
25
N/A
|
28
+14%
|
105
+275%
|
67
-36%
|
88
+31%
|
46
-48%
|
121
+166%
|
92
-24%
|
62
-32%
|
|
| Liabilities | ||||||||||
| Accounts Payable |
0
|
0
|
2
|
1
|
1
|
2
|
3
|
7
|
8
|
|
| Accrued Liabilities |
0
|
0
|
2
|
3
|
4
|
4
|
5
|
5
|
5
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
2
|
4
|
2
|
1
|
1
|
2
|
4
|
12
|
4
|
|
| Total Current Liabilities |
2
|
4
|
6
|
6
|
6
|
8
|
12
|
24
|
18
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
2
N/A
|
4
+93%
|
6
+35%
|
6
-4%
|
6
+2%
|
8
+36%
|
12
+54%
|
24
+94%
|
18
-24%
|
|
| Equity | ||||||||||
| Common Stock |
0
|
4
|
2
|
2
|
3
|
3
|
3
|
4
|
4
|
|
| Retained Earnings |
0
|
0
|
70
|
104
|
146
|
191
|
204
|
249
|
306
|
|
| Additional Paid In Capital |
0
|
0
|
163
|
164
|
225
|
225
|
309
|
313
|
346
|
|
| Other Equity |
22
|
20
|
4
|
0
|
0
|
0
|
0
|
204
|
0
|
|
| Total Equity |
22
N/A
|
24
+5%
|
99
+320%
|
62
-38%
|
82
+33%
|
37
-54%
|
109
+190%
|
68
-38%
|
44
-35%
|
|
| Total Liabilities & Equity |
25
N/A
|
28
+14%
|
105
+275%
|
67
-36%
|
88
+31%
|
46
-48%
|
121
+166%
|
92
-24%
|
62
-32%
|
|
| Shares Outstanding | ||||||||||
| Common Shares Outstanding |
12
|
12
|
20
|
20
|
30
|
30
|
35
|
35
|
39
|
|
Switch to:
Switch to:
See Also
Discover More
